There is an urgent need for new antimicrobial agents because antibiotic resistance has become so prevalent. But a promising class of such agents, known as RAMPs, may suffer from the same problem.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Perron, G. G., Zasloff, M. & Bell, G. Proc. R. Soc. Lond. B doi:rspb.2005.3301 (2005).
Zasloff, M. Nature 415, 389–395 (2002).
Mygind, P. H. et al. Nature 437, 975–980 (2005).
Bell, G. & Gouyon, P. -H. Microbiology 149, 1367–1375 (2003).
Trevor, F. C. & McDonald, L. C. Curr. Opin. Infect. Dis. 18, 300–305 (2005).
Ge, Y. et al. Antimicrob. Agents Chemother. 43, 782–788 (1999).
Steinberg, D. A. et al. Antimicrob. Agents Chemother. 41, 1738–1742 (1997).
Maisnier-Patin, S. & Andersson, D. S. Res. Microbiol. 150, 360–369 (2004).
Schrag, S. J. et al. Proc. R. Soc. Lond. B 264, 1287–1291 (1997).
Fedtke, I., Gotz, F. & Peschel, A. Int. J. Med. Microbiol. 294, 189–194 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buckling, A., Brockhurst, M. RAMP resistance. Nature 438, 170–171 (2005). https://doi.org/10.1038/438170a
Published:
Issue Date:
DOI: https://doi.org/10.1038/438170a
